I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 7 studies | 35% ± 17% | |
| CD4-positive, alpha-beta T cell | 5 studies | 19% ± 5% | |
| natural killer cell | 5 studies | 17% ± 2% | |
| endothelial cell | 4 studies | 23% ± 9% | |
| hematopoietic precursor cell | 3 studies | 25% ± 7% | |
| fibroblast | 3 studies | 22% ± 5% | |
| pericyte | 3 studies | 18% ± 3% | |
| ciliated cell | 3 studies | 26% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| regulatory T cell | 3 studies | 19% ± 3% | |
| dendritic cell | 3 studies | 28% ± 4% | |
| intestinal crypt stem cell | 3 studies | 21% ± 1% |
